Virtus Wealth Solutions LLC Acquires 36,465 Shares of Astera Labs, Inc. $ALAB

Key Points

• Virtus Wealth Solutions LLC increased its ownership in Astera Labs, acquiring an additional 36,465 shares, resulting in an 81.6% boost to its total stake during the 2nd quarter.
• Astera Labs reported a 149.5% increase in revenue year-over-year, with Q2 earnings per share exceeding expectations by $0.11.
• Insiders have sold a total of 1,320,054 shares of Astera Labs stock in the last three months, indicating significant trading activity by company executives.

Virtus Wealth Solutions LLC boosted its stake in Astera Labs, Inc. (NASDAQ:ALAB - Free Report) by 81.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 81,165 shares of the company's stock after acquiring an additional 36,465 shares during the period. Astera Labs accounts for approximately 1.5% of Virtus Wealth Solutions LLC's holdings, making the stock its 18th biggest holding. Virtus Wealth Solutions LLC's holdings in Astera Labs were worth $7,339,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Oliver Lagore Vanvalin Investment Group purchased a new stake in shares of Astera Labs in the 2nd quarter worth about $29,000. Sound Income Strategies LLC raised its stake in Astera Labs by 34.7% in the first quarter. Sound Income Strategies LLC now owns 792 shares of the company's stock worth $47,000 after buying an additional 204 shares in the last quarter. GAMMA Investing LLC lifted its holdings in Astera Labs by 55.7% in the first quarter. GAMMA Investing LLC now owns 794 shares of the company's stock worth $47,000 after buying an additional 284 shares during the period. Harbour Investments Inc. lifted its holdings in Astera Labs by 351.7% in the first quarter. Harbour Investments Inc. now owns 795 shares of the company's stock worth $47,000 after buying an additional 619 shares during the period. Finally, Migdal Insurance & Financial Holdings Ltd. bought a new stake in Astera Labs during the 1st quarter valued at approximately $48,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $212.10 on Wednesday. Astera Labs, Inc. has a 1 year low of $47.13 and a 1 year high of $262.90. The firm's 50-day moving average is $193.63 and its 200 day moving average is $121.53. The stock has a market cap of $35.26 billion, a price-to-earnings ratio of 378.75, a PEG ratio of 5.50 and a beta of 1.43.

Astera Labs (NASDAQ:ALAB - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. The business had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. Astera Labs's revenue was up 149.5% compared to the same quarter last year. During the same period last year, the business earned $0.13 EPS. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ALAB has been the subject of several research reports. Wall Street Zen lowered Astera Labs from a "buy" rating to a "hold" rating in a research report on Friday, October 3rd. Zacks Research raised Astera Labs to a "strong-buy" rating in a research note on Tuesday, August 12th. Stifel Nicolaus set a $145.00 price objective on Astera Labs and gave the company a "buy" rating in a research report on Monday, August 4th. Cowen assumed coverage on shares of Astera Labs in a report on Tuesday, September 30th. They set a "hold" rating on the stock. Finally, CICC Research assumed coverage on shares of Astera Labs in a research report on Friday, August 29th. They issued an "outperform" rating and a $190.00 target price on the stock. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and seven have issued a Hold rating to the company's stock. According to MarketBeat, Astera Labs has a consensus rating of "Moderate Buy" and a consensus price target of $159.83.

Insiders Place Their Bets

In other Astera Labs news, COO Sanjay Gajendra sold 280,000 shares of the stock in a transaction on Thursday, August 7th. The stock was sold at an average price of $170.02, for a total transaction of $47,605,600.00. Following the sale, the chief operating officer directly owned 5,525,545 shares in the company, valued at approximately $939,453,160.90. This trade represents a 4.82% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Manuel Alba sold 183,000 shares of the business's stock in a transaction on Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the transaction, the director owned 385,863 shares of the company's stock, valued at $66,858,482.01. This represents a 32.17% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 1,320,054 shares of company stock valued at $215,638,632. Insiders own 12.50% of the company's stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.

Want to see what other hedge funds are holding ALAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astera Labs, Inc. (NASDAQ:ALAB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.